Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Intangibles (2016 - 2022)

Abeona Therapeutics (ABEO) has 11 years of Intangibles data on record, last reported at $2.2 million in Q3 2022.

  • For Q3 2022, Intangibles rose 52.58% year-over-year to $2.2 million; the TTM value through Sep 2022 reached $2.2 million, up 52.58%, while the annual FY2021 figure was $2.2 million, 0.0% changed from the prior year.
  • Intangibles reached $2.2 million in Q3 2022 per ABEO's latest filing, roughly flat from $2.2 million in the prior quarter.
  • Across five years, Intangibles topped out at $44.9 million in Q4 2018 and bottomed at $1.4 million in Q3 2021.
  • Average Intangibles over 5 years is $13.8 million, with a median of $3.2 million recorded in 2018.
  • Peak YoY movement for Intangibles: skyrocketed 1027.96% in 2018, then crashed 93.75% in 2020.
  • A 5-year view of Intangibles shows it stood at $44.9 million in 2018, then decreased by 16.47% to $37.5 million in 2019, then crashed by 94.25% to $2.2 million in 2020, then changed by 0.0% to $2.2 million in 2021, then changed by 0.0% to $2.2 million in 2022.
  • Per Business Quant database, its latest 3 readings for Intangibles were $2.2 million in Q3 2022, $2.2 million in Q2 2022, and $2.2 million in Q1 2022.